Awaiting Left ventricular assist device implantation
Showing 1 - 25 of >10,000
Acute on Chronic Systolic CHF, Cardiorenal Syndrome Trial in Ann Arbor (Selective Cytopheretic Device)
Recruiting
- Acute on Chronic Systolic Congestive Heart Failure
- Cardiorenal Syndrome
- Selective Cytopheretic Device
-
Ann Arbor, MichiganUniversity of Michigan
Oct 31, 2022
Heart Failure, Right Ventricular Dysfunction, Right Ventricular Failure Trial in Chicago (Standardized RV Management, Usual Care
Not yet recruiting
- Heart Failure
- +2 more
- Standardized RV Management
- Usual Care RV Management
-
Chicago, IllinoisUniversity of Chicago
Feb 24, 2023
Ventricular Tachycardia Ablation in LVAD Patients
Not yet recruiting
- Ventricular Tachycardia
- +3 more
- Ablation
- (no location specified)
Sep 25, 2023
Left Ventricular Assist Device Implantation Patients
Completed
- Heart Failure
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Jun 3, 2022
Left Ventricular Assist Device Patients
Completed
- End-stage Heart Failure
- +2 more
- VerifyNow antiplatelet therapy response test
-
Vienna, AustriaMedical University of Vienna
Nov 28, 2023
Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)
Recruiting
- Heart Failure
- Mechanical Circulatory Support
- CD34+ stem cell therapy
-
Ljubljana, SloveniaUniversity Medical Center Ljubljana
Nov 22, 2023
Right Ventricular Function on Changes in Exercise Capacity After
Withdrawn
- Heart Failure With Reduced Ejection Fraction
- Left Ventricular Assist Device
- (no location specified)
Jun 14, 2023
Tricuspid Valve Insufficiency, Right Heart Failure, Heart Failure Trial in Durham (Tricuspid valve repair or replacement,
Active, not recruiting
- Tricuspid Valve Insufficiency
- +2 more
- Tricuspid valve repair or replacement
- Medical management of tricuspid regurgitation
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
RV Function in Patients Undergoing LVAD Implantation
Recruiting
- Heart Failure
-
Edmonton, Alberta, CanadaMazankowski Alberta Heart Institute
May 16, 2022
A Study of Glycemic Control in Left Ventricular Assist
Not yet recruiting
- Type 2 Diabetes Mellitus
- +2 more
- Freestyle Libre 3 Continuous Glucose Monitor (CGM)
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Right Heart Failure Trial in Roma (Pulmonary Vasodilators)
Recruiting
- Right Heart Failure
- Pulmonary Vasodilators
-
Roma, ItalySan Camillo Hospital
Apr 18, 2023
High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)
Active, not recruiting
- High-Risk Percutaneous Coronary Intervention
- The Elevate™ System
-
Tbilisi, GeorgiaIsraeli-Georgian Medical Research Clinic "Helsicore"
Oct 24, 2023
Angiodysplastic Bleeding Trial in Gainesville (Intravenous Infusion of UCLSCs)
Active, not recruiting
- Angiodysplastic Bleeding
- Intravenous Infusion of UCLSCs
-
Gainesville, FloridaUniversity of Florida
Sep 12, 2022
Advanced Heart Failure Trial in Tel Aviv
Recruiting
- Advanced Heart Failure
-
Tel Aviv, IsraelTel Aviv Sourasky Medical Center
Feb 26, 2022
High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- The Elevate™ System
-
New York, New YorkNew York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023
Right Ventricle Using Pressure-volume Loop Catheter and
Recruiting
- Right Ventricular Dysfunction
- Hemodynamic assessment
-
Minneapolis, MinnesotaUniversity of Minnesota
May 2, 2022
Cardiogenic Shock Trial in Marseille (IMPELLA CP, Conventional therapy)
Recruiting
- Cardiogenic Shock
- IMPELLA CP
- Conventional therapy
-
Marseille, Bouche DU Rhone, FranceAssistance Publique Hopitaux de Marseille
Jan 23, 2023
Thromboembolism, Hemolysis, Stroke Trial in United States (Lavare On, Lavare Off)
Terminated
- Thromboembolism
- +2 more
- Lavare On
- Lavare Off
-
Birmingham, Alabama
- +3 more
Jan 13, 2022
End-stage Heart Failure Trial in Bron (HeartMate 3 TM Left Ventricular Assist System, Guideline Directed Medical Therapy)
Recruiting
- End-stage Heart Failure
- HeartMate 3 TM Left Ventricular Assist System
- Guideline Directed Medical Therapy
-
Bron, FranceHôpital Pneumologique et Cardiovasculaire Louis Pradel
May 17, 2022
Heart Failure Trial in Essen (Training)
Completed
- Heart Failure
- Training
-
Essen, GermanyUniklinikum Essen
Oct 5, 2022
Human/Machine Interface: What HeartMate 3 ® Device Tells Us
Not yet recruiting
- LVAD
- +7 more
- HeartMate 3 (R) left ventricular assist device
- (no location specified)
Sep 8, 2023
Left Ventricular Assist Device Trial in Bern (Blood-pressure measuring (Nellcor™ Adult SpO2 Sensor))
Completed
- Left Ventricular Assist Device
- Blood-pressure measuring (Nellcor™ Adult SpO2 Sensor)
-
Bern, SwitzerlandUniversity Hospital Bern
Nov 22, 2021
Distributive Shock Trial in Chicago (Angiotensin II, Placebo)
Not yet recruiting
- Distributive Shock
- Angiotensin II
- Placebo
-
Chicago, IllinoisNorthwestern University
Feb 13, 2022
Arrythmia, Cardiomyopathies Trial in Rochester (Intra-Op Prophylactic VT ablation, Conventional Management)
Recruiting
- Arrythmia
- Cardiomyopathies
- Intra-Op Prophylactic VT ablation
- Conventional Management
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
Ischemic Heart Disease, Non-ischemic Cardiomyopathy Trial in Washington (Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC),
Terminated
- Ischemic Heart Disease
- Non-ischemic Cardiomyopathy
- Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)
- Placebo
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jan 3, 2022